Target intelligence / Profile preview

RN7SK pseudogene 283 (RN7SKP283)

Target
RN7SKP283
Molecular classification
Other
01

Overview

RN7SK pseudogene 283 (RN7SKP283) is classified as a pseudogene, specifically a non-coding RNA gene that is related to, but distinct from, the functional RN7SK (7SK small nuclear RNA) gene. Pseudogenes typically do not code for functional RNA or protein products, and there is no evidence linking RN7SKP283 to specific molecular interactions, drug targets, or disease associations. In contrast, the canonical 7SK RNA is a regulatory non-coding RNA that controls transcription elongation in cells, but pseudogenes like RN7SKP283 are generally not involved in such essential cellular or disease processes. RN7SK pseudogene 283 is annotated as a pseudogene in human genomic databases with no established biological or therapeutic relevance. There is no data to support RN7SKP283 acting as a therapeutic target or functioning as a receptor, enzyme, transporter, or other target class. The true 7SK small nuclear RNA plays a pivotal role in regulating RNA polymerase II transcription elongation and mRNA production in cooperation with protein complexes such as P-TEFb and HEXIM1. However, the pseudogene version RN7SKP283 does not participate in or regulate these pathways. No known disease associations or drug interactions are reported for RN7SKP283. The entry for "RN7SK pseudogene 283" is not a therapeutic or functional target but a genomic pseudogene with no known biological activity, drug interactions, or disease associations. If you need details about the actual functional RNA (7SK snRNA), please clarify, as that is a well-characterized regulatory non-coding RNA.

Other names
RNA, 7SK small nuclear pseudogene 283RN7SKP283

Beyond the preview

Go deeper on RN7SK pseudogene 283 (RN7SKP283).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 283 (RN7SKP283).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call